Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04393558 · ClinicalTrials.gov registry record
Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms
A clinical trial, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- 75
- Enrollment target
NCT04393558: Completed study, sponsored by Shirley Ryan AbilityLab.
NCT04393558 is a clinical trial that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04393558 has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
1. Develop a wearable sensor package to gather data on COVID-19-like signs and symptoms such as elevated body temperature, respiratory parameters, heart rate ,cough and gait. 2. Create algorithms to monitor and track changes to COVID19-like signs and symptoms for developing a better care and isolation strategies for COVID-19 pandemic.
Primary Outcome
Body temperature : Periodic temperature readings over the day (every 15 minutes)
Interventions
- DEVICE ADAM Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2020-10-26 |
What the finished NCT04393558 record still lists
NCT04393558 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ADAM Sensor is the first listed.
NCT04393558 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04393558 about?
NCT04393558 is a clinical study titled "Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms". 1. Develop a wearable sensor package to gather data on COVID-19-like signs and symptoms such as elevated body temperature, respiratory parameters, heart rate ,cough and gait. 2. Create algorithms to monitor and track changes to COVID19-like signs and symptoms for developing a better care and isolati...
What is the current status of trial NCT04393558?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2020-04-20. Estimated completion is 2020-10-26.
What interventions are being tested in trial NCT04393558?
The interventions under investigation include: ADAM Sensor (DEVICE).
Who is sponsoring clinical trial NCT04393558?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI